Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
China flag China · Delayed Price · Currency is CNY
41.82
-0.40 (-0.95%)
Jul 31, 2026, 3:00 PM CST

SHA:688050 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
656.7629.81363.9536.66354.9472.87
Short-Term Investments
-----480
Trading Asset Securities
72.13166.33132.2720.12481.970.48
Cash & Short-Term Investments
728.83796.14496.17556.78836.86953.35
Cash Growth
47.11%60.46%-10.89%-33.47%-12.22%-3.42%
Accounts Receivable
691.28470.46353.15212.82103.5267.8
Other Receivables
10.399.285.346.033.716.57
Receivables
701.67479.73358.49218.85107.2374.37
Inventory
398.88313.22272.63181.3578.8356.02
Prepaid Expenses
-----0.15
Other Current Assets
111.9380.9553.3465.8938.3634.83
Total Current Assets
1,9411,6701,1811,0231,0611,119
Property, Plant & Equipment
1,4561,4281,5031,257674.21558.69
Long-Term Investments
157.12127.55207.83157.44153.56102.16
Goodwill
657.93148.77139.11132.621.1321.13
Other Intangible Assets
231.51234.21190.43174.21107.0491.39
Long-Term Deferred Tax Assets
103.7389.7172.8946.7429.9134.35
Long-Term Deferred Charges
161.34145.63149.56105.7260.8367.49
Other Long-Term Assets
55.6126.9736.85149.43120.8145.49
Total Assets
4,7653,8883,4973,0622,2442,048

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
101.5660.0356.0849.0513.865.57
Accrued Expenses
43.460.3855.7450.8742.5931.82
Short-Term Debt
95.225-25.55--
Current Portion of Long-Term Debt
253.06190.6580.8392.39--
Current Portion of Leases
-4.424.71---
Current Income Taxes Payable
35.628.453.772.3113.56.99
Current Unearned Revenue
20.447.2811.4612.66.476.16
Other Current Liabilities
74.5487.5486.3214571.2988.88
Total Current Liabilities
623.84423.75298.91377.77147.71139.42
Long-Term Debt
930.48377.25513.13287.44149.77143.37
Long-Term Leases
20.1624.1910.2313.8513.0211.48
Long-Term Unearned Revenue
32.9732.8722.3510.538.910.76
Long-Term Deferred Tax Liabilities
15.0513.916.2615.144.260.8
Other Long-Term Liabilities
15.7945.691.821.130.641.63
Total Liabilities
1,638917.65862.71705.85324.3307.46

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
193.4193.4189.54105.25105.18105.14
Additional Paid-In Capital
1,3551,3701,1971,3251,3111,318
Retained Earnings
1,3321,2421,037699.81444.01250.23
Treasury Stock
-20.04-20.04-20.04---
Comprehensive Income & Other
4.043.466.33---
Total Common Equity
2,8642,7892,4092,1301,8601,674
Minority Interest
262.72181.49224.76226.359.9666.29
Shareholders' Equity
3,1272,9702,6342,3561,9201,740
Total Liabilities & Equity
4,7653,8883,4973,0622,2442,048

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,299601.5608.9419.23162.79154.85
Net Cash (Debt)
-570.1194.64-112.73137.55674.07798.5
Net Cash Growth
----79.59%-15.58%-19.11%
Net Cash Per Share
-2.961.02-0.600.723.564.22
Filing Date Shares Outstanding
193.4193.4189.54189.45189.32189.25
Total Common Shares Outstanding
193.4193.4189.54189.45189.32189.25
Working Capital
1,3171,246881.72645.1913.59979.3
Book Value Per Share
14.8114.4212.7111.249.838.84
Tangible Book Value
1,9742,4062,0801,8231,7321,561
Tangible Book Value Per Share
10.2112.4410.979.629.158.25
Buildings
-881.48879.35676.61414.46150.37
Machinery
-959.48874.05618.13232.76155.95
Construction In Progress
-23.752.88154.26120.6318.44